<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="5634" whole_study_id="5634" phs="000183" v="1" p="1" createDate="2009-07-06T13:24:01-05:00" modDate="2022-02-16T17:13:04-05:00" maxParentChildStudyModDate="2022-02-16T17:13:04-05:00" handle="NIDDK_BiliaryCirrhosis_Hirschfield" num_participants="2072"><StudyInfo accession="phs000183.v1.p1" parentAccession="phs000183.v1.p1"><StudyNameEntrez>Genome-wide association study of primary biliary cirrhosis </StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>analysis</StudyType></StudyTypes><Description>
&lt;p&gt;Primary biliary cirrhosis (PBC) is a chronic destructive granulomatous cholangitis, characteristically associated

 with anti-mitochondrial antibodies. Twin and family aggregation data suggest significant genetic predisposition, but the

 susceptibility loci for PBC are unknown. To identify genetic loci conferring risk for PBC, we carried out a genomewide

 association (GWA) analysis in which 2072 North American subjects (536 PBC cases; 1536 controls) were genotyped for over

 300,000 single nucleotide polymorphisms (SNPs). Sixteen of the most strongly associated SNPs were genotyped in two

 independent replication sets (US based: 410 PBC cases; 310 controls and Canada based: 116 cases; 896 controls). Fine-mapping

 studies across three PBC-associated loci were also performed in 1900 Canada based subjects (621 cases; 1279 controls).&lt;/p&gt;

 &lt;p&gt;Modified from &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/19458352" target="_blank"&gt;Hirschfield et al&lt;/a&gt;. Primary Biliary

 Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants.&lt;/p&gt;
 </Description><StudyHistory>
&lt;p&gt;This study was initiated in 2004 and a pan-Canadian clinical network established for sample collection/processing.&lt;/p&gt;
 </StudyHistory><Attributions><Header title="Principal Investigator"><AttrName>Katherine Siminovitch, MD</AttrName><Institution>Department of Medicine, University of Toronto, Toronto, Canada</Institution></Header><Header title="Funding Source"><AttrName>MOP 74621</AttrName><Institution>Canadian Institute of Health Research</Institution></Header></Attributions><Publications><Publication><Pubmed pmid="19458352"/></Publication><Publication><Pubmed pmid="18625125"/></Publication><Publication><Pubmed pmid="18773895"/></Publication><Publication><Pubmed pmid="18778710"/></Publication><Publication><Pubmed pmid="18456185"/></Publication></Publications><Funding>R01 DK080670-02</Funding></StudyInfo><Authority><ICs><IC id="11" name="NIDDK" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="LAZARIDIS1" aid="2" auth="eRA" login="LAZARIDIS1" fname="Konstantinos" mname="N" lname="Lazaridis" email="lazaridis.konstantinos@mayo.edu"><Role>PI</Role><Organization>MAYO CLINIC ROCHESTER</Organization></Person><Person nedid="0010067753" aid="1" auth="cit" login="karpr" fname="Robert" mname="W" lname="Karp" email="karpr@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2003219528" aid="1" auth="cit" login="pawlikowskals" fname="Ludmila" mname="Sylwia" lname="Pawlikowska" email="ludmila.pawlikowska@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>INSTRUCTIONS:  This study has not provided a suggested acknowledgement statement. However, Approved Users are expected to acknowledge the Submitting Investigator(s) who submitted data from the original study to an NIH-designated data repository, the primary funding organization that supported the Submitting Investigator(s), and the NIH-designated data repository (e.g., dbGaP).  The acknowledgment statement should include the dbGaP accession number to the specific version of the dataset(s) analyzed.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="163" CGType="cg_class_GRU" title="General Research Use (IRB)" name="GRU-IRB" dac_uid="60" dac_name="NIDDK" irb-approval-required="Yes"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.
Requestor must provide documentation of local IRB approval.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="3" name="incomplete" title="Incomplete"/></Study></dbgapss>